Bridging phase 2 and phase 3 pneumococcal immunologic data for future combination vaccines.
about
Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of ageSafety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein--conjugated pneumococcal vaccine in Filipino infantsAssignment of weight-based antibody units for 13 serotypes to a human antipneumococcal standard reference serum, lot 89-S(f).Assignment of weight-based immunoglobulin G1 (IgG1) and IgG2 units in antipneumococcal reference serum lot 89-S(F) for pneumococcal polysaccharide serotypes 1, 4, 5, 7F, 9V, and 18C
P2860
Bridging phase 2 and phase 3 pneumococcal immunologic data for future combination vaccines.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Bridging phase 2 and phase 3 p ...... r future combination vaccines.
@ast
Bridging phase 2 and phase 3 p ...... r future combination vaccines.
@en
type
label
Bridging phase 2 and phase 3 p ...... r future combination vaccines.
@ast
Bridging phase 2 and phase 3 p ...... r future combination vaccines.
@en
prefLabel
Bridging phase 2 and phase 3 p ...... r future combination vaccines.
@ast
Bridging phase 2 and phase 3 p ...... r future combination vaccines.
@en
P2860
P356
P1476
Bridging phase 2 and phase 3 p ...... r future combination vaccines.
@en
P2093
P2860
P304
P356
10.1086/322565
P407
P478
33 Suppl 4
P577
2001-12-01T00:00:00Z